Hemophilia Association Of New Jersey
Hemophilia Association Of New Jersey: Consistent Revenue, High Program Spending
EIN: 221964188 · East Brunswick, NJ · Updated: 2026-04-04
| Metric | Value |
|---|---|
| Total Revenue | $1.5M |
| Total Expenses | $1.0M |
| Program Spending | 82% |
| CEO/Top Officer Pay | $0 |
| Net Assets | $5.4M |
| Transparency Score | 85/100 |
Is Hemophilia Association Of New Jersey Legit?
Some Concerns
Assessment based on IRS 990 filings, spending patterns, and AI analysis. Not a guarantee of legitimacy. Full charity check →
Hemophilia Association Of New Jersey directs 82% of its spending to programs. This exceeds the industry benchmark of 65%, indicating strong mission focus.
About Hemophilia Association Of New Jersey
Hemophilia Association Of New Jersey (EIN: 221964188) is a nonprofit organization based in East Brunswick, NJ. The organization reported total revenue of $1.5M and total assets of $5.9M according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of Hemophilia Association Of New Jersey's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.
Organization Overview
Hemophilia Association Of New Jersey is a mid-size nonprofit that has been operating for 34 years, with 12 years of IRS 990 filings on record (2011–2023). Revenue has grown at a compound annual rate of -3.7%.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
| Total Revenue | $1.2M |
| Total Expenses | $1.0M |
| Surplus / Deficit | +$220K |
| Total Assets | $5.7M |
| Total Liabilities | $262K |
| Net Assets | $5.4M |
| Operating Margin | 17.6% |
| Debt-to-Asset Ratio | 4.6% |
| Months of Reserves | 66.7 months |
Financial Health Grade: A
In 2023, Hemophilia Association Of New Jersey reported a surplus of $220K with revenue exceeding expenses, holds 66.7 months of operating reserves (strong position), has a debt-to-asset ratio of 4.6% (very low leverage).
Financial Trends
Over 12 years of filings (2011–2023), Hemophilia Association Of New Jersey's revenue has declined at a compound annual growth rate (CAGR) of -3.7%.
| Year | Revenue Change | Expense Change | Asset Change |
|---|---|---|---|
| 2023 | +10.1% | -5.4% | +7.3% |
| 2022 | +8.3% | -5.4% | +6.2% |
| 2020 | -20.2% | +3.1% | -2.5% |
| 2019 | -13.5% | -18.0% | +8.7% |
| 2018 | +5.4% | +6.2% | +0.5% |
IRS Tax-Exempt Classification
| IRS Classification Codes | 1000 |
| IRS Ruling Date | 1992 |
Classification data from ProPublica Nonprofit Explorer. Additional BMF data may be available after enrichment.
AI Transparency Report
Mission Effectiveness Score
NonprofitSpending's AI analysis rates Hemophilia Association Of New Jersey with a Mission Score of 85 out of 100 (Excellent). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.
Spending Breakdown
- admin: 10%
- programs: 82%
- fundraising: 8%
According to IRS 990 filings, Hemophilia Association Of New Jersey allocates its expenses as follows: admin: 10%, programs: 82%, fundraising: 8%. With 82% directed toward programs, this reflects a strong commitment to its charitable mission.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
- The organization reported a surplus of $220K, with revenue exceeding expenses.
- Debt-to-asset ratio: 4.6%.
Executive Compensation Analysis
Executive compensation is reported as $0 across all available filings, indicating that key personnel are either volunteers or compensated through other means not disclosed in this section of the 990.
Executive compensation data is sourced from IRS 990 filings, which require nonprofits to disclose the compensation of officers, directors, trustees, and key employees. NonprofitSpending analyzes this data relative to the organization's total revenue and sector benchmarks to assess whether executive pay is reasonable.
Red Flags
The following concerns were identified during AI analysis of Hemophilia Association Of New Jersey's IRS 990 filings:
- The consistent reporting of $0 for officer compensation across multiple years could indicate that compensation is being reported in other categories or that the organization is entirely volunteer-run at the executive level, which warrants further investigation for clarity.
Strengths
The following positive indicators were identified for Hemophilia Association Of New Jersey:
- A high percentage of expenses are consistently allocated to programs (82% in 2023), demonstrating a strong commitment to their mission.
- The organization maintains a robust asset base, with total assets of $5,698,372 in 2023, providing financial resilience.
- Low liabilities ($262,056 in 2023) suggest sound financial health and responsible debt management.
- Revenue has remained relatively stable over the past several years, indicating consistent donor support and funding streams.
- The organization has consistently operated with a surplus or near-break-even, demonstrating effective financial planning.
Frequently Asked Questions about Hemophilia Association Of New Jersey
Is Hemophilia Association Of New Jersey a legitimate charity?
Based on AI analysis of IRS 990 filings, Hemophilia Association Of New Jersey (EIN: 221964188) some concerns. Mission Score: 85/100. 1 red flag identified, 5 strengths noted.
How does Hemophilia Association Of New Jersey spend its money?
Hemophilia Association Of New Jersey directs 82% of its spending to programs and services. The remaining budget covers administration and fundraising costs.
Are donations to Hemophilia Association Of New Jersey tax-deductible?
Hemophilia Association Of New Jersey is registered as a tax-exempt nonprofit (EIN: 221964188). Donations to most 501(c)(3) organizations are tax-deductible. Consult a tax professional for your specific situation.
How much does the Hemophilia Association Of New Jersey CEO make?
Hemophilia Association Of New Jersey's highest-compensated officer earns $0 annually. The organization reported $1.5M in total revenue. Executive compensation data is disclosed in IRS 990 filings.
What percentage of Hemophilia Association Of New Jersey's spending goes to programs?
Hemophilia Association Of New Jersey directs 82% to programs, 8% to fundraising. This exceeds the 65% industry benchmark for efficient nonprofits.
Where is Hemophilia Association Of New Jersey located?
Hemophilia Association Of New Jersey is headquartered in East Brunswick, New Jersey and files with the IRS under EIN 221964188.
How many years of IRS 990 filings does Hemophilia Association Of New Jersey have?
Hemophilia Association Of New Jersey has 12 years of IRS 990 filings on record at NonprofitSpending. This extensive filing history provides a strong basis for evaluating long-term financial trends. The most recent filing shows $1.5M in total revenue.
What does Hemophilia Association Of New Jersey do?
Hemophilia Association Of New Jersey is a nonprofit organization in the Unknown sector, located in East Brunswick, New Jersey. It is classified under NTEE code Unknown.
How much revenue does Hemophilia Association Of New Jersey have?
Hemophilia Association Of New Jersey reported total revenue of $1,519,117. Based on 12 IRS 990 filings on record.
What are Hemophilia Association Of New Jersey's total assets?
Hemophilia Association Of New Jersey holds total assets of $5,947,115 as reported in IRS 990 filings.
Where is Hemophilia Association Of New Jersey located?
Hemophilia Association Of New Jersey is based in East Brunswick, New Jersey.
What is Hemophilia Association Of New Jersey's EIN?
Hemophilia Association Of New Jersey's Employer Identification Number (EIN) is 221964188. This is the unique tax ID assigned by the IRS for tax-exempt organizations.
What type of nonprofit is Hemophilia Association Of New Jersey?
Hemophilia Association Of New Jersey is classified under NTEE code Unknown (Unknown).
Is Hemophilia Association Of New Jersey a registered 501(c)(3)?
Hemophilia Association Of New Jersey appears in IRS records (EIN: 221964188). Check the IRS Tax Exempt Organization Search for the most current determination letter status.
Does Hemophilia Association Of New Jersey file IRS Form 990?
Yes, Hemophilia Association Of New Jersey has 12 IRS Form 990 filings on record. The most recent covers tax period 202306.
What was Hemophilia Association Of New Jersey's revenue in 2023?
In the 202306 filing period, Hemophilia Association Of New Jersey reported total revenue of $1,244,928, total expenses of $1,025,326, and net assets of $5,698,372.
Is Hemophilia Association Of New Jersey's revenue growing or declining?
Hemophilia Association Of New Jersey's revenue is growing. Revenue went from $1,130,700 (202206) to $1,244,928 (202306), a +10.1% change. Based on 12 filings on record.
What is Hemophilia Association Of New Jersey's most recent 990 filing?
The most recent IRS Form 990 filing for Hemophilia Association Of New Jersey covers tax period 202306. It shows revenue of $1,244,928, expenses of $1,025,326, total assets of $5,698,372, and liabilities of $262,056.
How much does Hemophilia Association Of New Jersey spend on programs vs administration?
Based on IRS 990 analysis, Hemophilia Association Of New Jersey allocates approximately 82% of expenses to program services, 10% to administrative costs, and 8% to fundraising. This indicates strong program focus.
Is Hemophilia Association Of New Jersey a trustworthy charity?
Based on AI analysis of IRS 990 data, Hemophilia Association Of New Jersey appears trustworthy. Mission Score: 85/100 (Excellent). 1 red flag identified. 5 strengths noted.
What are the red flags for Hemophilia Association Of New Jersey?
The following concerns were identified: The consistent reporting of $0 for officer compensation across multiple years could indicate that compensation is being reported in other categories or that the organization is entirely volunteer-run at the executive level, which warrants further investigation for clarity.. These flags are based on automated analysis of IRS 990 public filings and should be verified independently.
What are Hemophilia Association Of New Jersey's strengths?
Positive indicators for Hemophilia Association Of New Jersey include: A high percentage of expenses are consistently allocated to programs (82% in 2023), demonstrating a strong commitment to their mission.. The organization maintains a robust asset base, with total assets of $5,698,372 in 2023, providing financial resilience.. Low liabilities ($262,056 in 2023) suggest sound financial health and responsible debt management.. Revenue has remained relatively stable over the past several years, indicating consistent donor support and funding streams.. The organization has consistently operated with a surplus or near-break-even, demonstrating effective financial planning.. These findings are derived from AI analysis of the organization's financial filings.
How does Hemophilia Association Of New Jersey compensate executives?
Executive compensation is reported as $0 across all available filings, indicating that key personnel are either volunteers or compensated through other means not disclosed in this section of the 990. Executive compensation data is sourced from IRS 990 filings, which require disclosure of officer, director, and key employee pay.
Given the consistent $0 executive compensation, how does the organization attract and retain leadership, and what are the actual costs associated with their operational management?
The consistent reporting of $0 for executive compensation suggests that leadership may be entirely volunteer-based or compensated through mechanisms not categorized under 'officers, directors, trustees, and key employees' on the 990. Further inquiry into their operational budget and staffing structure would be needed to understand the full cost of management and leadership.
Filing History
IRS 990 filing history for Hemophilia Association Of New Jersey showing financial trends over 12 years of public records:
Over 12 years of IRS 990 filings (2011–2023), Hemophilia Association Of New Jersey's revenue has declined by 36.1%, moving from $1.9M to $1.2M. Total assets increased by 46.6% over the same period, from $3.9M to $5.7M. Total functional expenses fell by 45.3%, from $1.9M to $1.0M. In its most recent filing year (2023), Hemophilia Association Of New Jersey reported a surplus of $220K, with revenue exceeding expenses. The organization holds $262K in liabilities against $5.7M in assets (debt-to-asset ratio: 4.6%), resulting in net assets of $5.4M.
| Year | Revenue | Expenses | Assets | Liabilities | Officer Comp. % | |
|---|---|---|---|---|---|---|
| 2023 | $1.2M | $1.0M | $5.7M | $262K | — | View 990 |
| 2022 | $1.1M | $1.1M | $5.3M | $95K | — | View 990 |
| 2020 | $1.0M | $1.1M | $5.0M | $250K | — | View 990 |
| 2019 | $1.3M | $1.1M | $5.1M | $199K | — | View 990 |
| 2018 | $1.5M | $1.4M | $4.7M | $75K | — | View 990 |
| 2017 | $1.4M | $1.3M | $4.7M | $62K | — | View 990 |
| 2016 | $1.6M | $1.3M | $4.6M | $140K | — | View 990 |
| 2015 | $1.8M | $1.8M | $4.3M | $115K | — | View 990 |
| 2014 | $1.8M | $1.8M | $4.8M | $567K | — | View 990 |
| 2013 | $2.5M | $2.1M | $5.1M | $975K | — | View 990 |
| 2012 | $1.8M | $1.9M | $4.0M | $249K | — | View 990 |
| 2011 | $1.9M | $1.9M | $3.9M | $76K | — | View 990 |
Year-by-Year Financial Summary
- 2023: Revenue of $1.2M, expenses of $1.0M, and assets of $5.7M (revenue +10.1% year-over-year).
- 2022: Revenue of $1.1M, expenses of $1.1M, and assets of $5.3M (revenue +8.3% year-over-year).
- 2020: Revenue of $1.0M, expenses of $1.1M, and assets of $5.0M (revenue -20.2% year-over-year).
- 2019: Revenue of $1.3M, expenses of $1.1M, and assets of $5.1M (revenue -13.5% year-over-year).
- 2018: Revenue of $1.5M, expenses of $1.4M, and assets of $4.7M (revenue +5.4% year-over-year).
- 2017: Revenue of $1.4M, expenses of $1.3M, and assets of $4.7M (revenue -8.3% year-over-year).
- 2016: Revenue of $1.6M, expenses of $1.3M, and assets of $4.6M (revenue -15.1% year-over-year).
- 2015: Revenue of $1.8M, expenses of $1.8M, and assets of $4.3M (revenue +1.9% year-over-year).
- 2014: Revenue of $1.8M, expenses of $1.8M, and assets of $4.8M (revenue -27.1% year-over-year).
- 2013: Revenue of $2.5M, expenses of $2.1M, and assets of $5.1M (revenue +35.6% year-over-year).
- 2012: Revenue of $1.8M, expenses of $1.9M, and assets of $4.0M (revenue -6.3% year-over-year).
- 2011: Revenue of $1.9M, expenses of $1.9M, and assets of $3.9M.
View Individual Filing Years
Explore detailed financial data from each IRS 990 filing year for Hemophilia Association Of New Jersey:
Data Sources and Methodology
This transparency report for Hemophilia Association Of New Jersey is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.
IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.
Disclaimer
AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.